CLINICAL SOLUTIONS COSMECEUTICALS LIMITEDActive

Company number SC570013Private limited companyIncorporated 2017

Key figures

£126,704+49.8%
Net assets 2024/25
+25.7%
Average annual growth 2019/20–2024/25
050 k100 k150 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, CLINICAL SOLUTIONS COSMECEUTICALS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Total assets85,70669,367130,334146,715192,087
Total liabilities2,630046,23752,63055,291
Net assets / total equity43,07025,12944,09184,581126,704
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

85590

As described in the company's latest filed accounts.

Summary: CLINICAL SOLUTIONS COSMECEUTICALS LIMITED

Company

CLINICAL SOLUTIONS COSMECEUTICALS LIMITED is a private limited company registered with Companies House under company number SC570013. It was incorporated on 29 Jun 2017. Its status is active. The registered office is in Glasgow (G43). Its nature of business (SIC 2007) is other education n.e.c. (85590).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files micro-entity accounts. Net assets were £126,704, up 49.8% on the previous year. Total assets were £192,087 and total liabilities £55,291. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 16 Jun 2027.